Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03025074 · ClinicalTrials.gov registry record
Blood Collection Biorepository for Liver Disease Research
A clinical trial of Hepatitis C and Cirrhosis, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03025074 is a study of Hepatitis C and Cirrhosis that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 1,000 participants, below the 1,881-participant average among 106 other Hepatitis C trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03025074, a study of Hepatitis C and Cirrhosis, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Conditions Studied
Study Locations (1)
New York
- University at Buffalo, Buffalo General Medical Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2013-07 |
| Est. Completion | 2099-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03025074
The ClinicalTrials.gov registry entry for NCT03025074 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,881-participant average among 106 other Hepatitis C trials with a reported enrollment target (47% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT03025074 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03025074 about?
NCT03025074 is a clinical study titled "Blood Collection Biorepository for Liver Disease Research". The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
What is the current status of trial NCT03025074?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2013-07. Estimated completion is 2099-12.
What conditions does trial NCT03025074 study?
This clinical trial studies the following conditions: Hepatitis C, Cirrhosis, Obesity, Childhood, Hepatitis B, Bariatric Surgery Candidate.
Who is sponsoring clinical trial NCT03025074?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03025074 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.